MIP Diagnostics Limited develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes.
Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics.
Business funding insights
How to grow your company through acquisition
Gurinder Sunner, head of BGF in the Midlands considers ‘How to grow your company through acquisition’ In its simplest form,…
Infrastructure spending is only one part of the solution
The chancellor is right to back an investment-led recovery, but infrastructure is only part of the solution. Business funding is needed too.